The ethics of psychedelic research in disorders of consciousness

von pgd | Nov 30, 2019 | Forschung

Abstract This article provides an ethical analysis of psychedelic research involving disorders of consciousness patients. We apply two internationally accepted approaches for analyzing the ethics of human research, the Value-Validity Framework and Component Analysis,...

Psychedelic Trauma is Real – K.J. Morris – Medium

von pgd | Nov 30, 2019 | International

Psychedelics are going through a serious revival right now. Clinical trials are taking place with LSD and psilocybin (magic mushrooms), MDMA is already being used to treat PTSD, and ketamine is being prescribed for depression (you’ve probably heard all of this...

Welt im Rausch

von pgd | Nov 30, 2019 | Aktuelles

Steuern wir auf eine Rausch-Gesellschaft zu? Legalisierung wird ein globaler Großtrend – und führt zu einem veränderten Bewusstsein des Selbst und der Gesellschaft. – Ein Auszug aus dem Zukunftsreport 2019. Mehr lesen… Quelle: Welt im Rausch

Toward a contextual psychedelic-assisted therapy: Perspectives from Acceptance and Commitment Therapy and contextual behavioral science – ScienceDirect

von pgd | Nov 30, 2019 | Forschung

Toward a contextual psychedelic-assisted therapy: Perspectives from Acceptance and Commitment Therapy and contextual behavioral science Abstract After two decades of quiescence, clinical psychedelic research re-started in the 1990s and is rapidly accelerating. Early...

Can a Trip-Free Psychedelic Still Help People With Depression? – VICE

von pgd | Nov 30, 2019 | International

Psilocybin has shown promise for conditions like depression. Now, researchers are asking if the psychedelic experience is absolutely necessary to treat mental health. A patient with depression once described their condition as „being enclosed in the most narrow...